Skip to content

A Powerful Story- An Evaluation Study of a Life Story Intervention to promote Recovery in People with Personality Disorders in the High Intensity Service of Mental Health Care.

A Powerful Story- An Evaluation Study of a Life Story Intervention to promote Recovery in People with Personality Disorders in the High Intensity Service of Mental Health Care.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24545
Enrollment
12
Registered
2018-12-20
Start date
2019-02-27
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Personality disorders

Interventions

It is a narrative intervention especially developed for patients suffering from personality disorder. The goal of the intervention is promoting personal and societal recovery in those patients. This r

Sponsors

Prof. dr. G.J. Westerhof (Hoofdonderzoeker) Functie: Hoogleraar narratieve psychologie T: 053-4896074 | E: g.j.westerhof@utwente.nl
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: To qualify for participation in this research, a patient must: 1. follow a treatment at Scelta, GGNet 2. Have been approved to participate by his responsible therapist 3. Be able to complete this intervention during the treatment at Scelta Explanation criterion 2: The main responsible therapist decides in consultation with the patient whether it is appropriate to participate in this intervention. The main responsible therapist makes use of the following screening criteria: - A patient must be able to look at the past with some distance, as indicated by at least one active contribution during the treatment program in a psychotherapie session (group session) - A patient must be able to look forward towards recovery, as demonstrated by at least one contribution during treatment program in the social reintegration part There is no inclusion criterion for therapists. It concerns practitioners who work at Scelta Apeldoorn.

Exclusion criteria

Exclusion criteria: The exclusion criteria for participation in this study are: - Low IQ (lower than 80) - Not able to participate in a group form - Antisocial personality disorder - Insufficient command of the Dutch language These criteria have already been screened during admission for treatment at Scelta. For taking part in 'A Powerful Story' they will be checked again by the main responsible therapist, who assesses whether the intervention seems feasible and suitable for the patient. In addition to the standard exclusion criteria, additional exclusion criteria are: - presence of contra-indication (such as severe instability or being in an acute crisis (GAF- score lower than 50) or the presence of psychosis or acute suicidality, implying no mental competence) There is no exclusion criterion for therapists. It concerns practitioners who work at Scelta Apeldoorn.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the feasibility of the intervention as reported by participants (patients and practitioners) and by an observer present at the sessions. This will be measured with the Client Satisfaction Questionnaire (CSQ, Larsen, Attkisson, Hargreaves, & Nguyen, 1979; Dutch translation: De Brey, 1983), which is administered to the practitioners after each session, the Helpful Aspects of Therapy form (HAT; Llewelyn et al., 1988; Elliot, 2012), which is administered to the patients after each session, the observations of adherence and treatment integrity at each session and the evaluation of the entire intervention afterwards (CSQ for both, practitioners and patients).

Secondary

MeasureTime frame
A second outcome measure is the change in recovery based on the Mental Health Recovery Measure (MHRM, van Nieuwenhuizen et al., 2013, Young & Bullock, 2005). A third outcome measure is the therapy course based on shared stories during the sessions and a qualitative analysis of the final product.

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)